Published March 22, 2016
| Version v1
Patent
Open
Method of treatment of prostate cancer with androgen receptor and glucocorticoid receptor antagonists
Contributors
Patent applicant:
Description
Methods are directed to the treatment of subjects with prostate cancer, in particular those with castration resistant prostate cancer, with glucocorticoid receptor antagonists. The prostate cancer may be one that has become resistant to androgen deprivation therapy, for example, by increase in glucocorticoid receptor expression and/or activity.
Files
US20150010503.pdf
Files
(1.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:92351d72b5b540b085da21c469cfc245
|
1.4 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 201314380606 A
- Patent application number
- US 9289436 B2
- Other
- oai:uchicago.tind.io:7868
Dates
- Patent filed
-
2013-02-21